For patients with metastatic triple-negative breast cancer, clinical activity with Trodelvy (sacituzumab govitecan) stays consistent, researchers found.Enhertu (trastuzumab deruxtecan) in ...
As more is understood about the subtypes of breast cancer and therapies to target them, an expert urged patients to ...
A medical expert discussed the importance of biomarkers in guiding treatment decisions for patients with metastatic breast cancer.Understanding the biomarkers ...
The FDA has approved an Itovebi combination for select patients with advanced or metastatic breast cancer. The Food and Drug ...
Treatment with Herceptin (trastuzumab) and Perjeta (pertuzumab) with endocrine therapy but without chemotherapy has been shown to potentially be an ...
Enhertu (T-DXd; fam-trastuzumab deruxtecan-nxki) reduced deterioration in physical and role functioning (ability to perform tasks) and pain compared with treatment ...
Effective metastatic breast cancer management requires a multidisciplinary approach, strong patient-doctor communication, and tailored treatments based on biomarkers.Although patients with ...
Patients with HR-positive, HER2-low or -ultralow metastatic breast cancer (MBC) treated with Enhertu (trastuzumab deruxtecan) had a reduced deterioration in ...
A new study reveals Enhertu effectively treats breast cancer that has spread to the brain, offering hope for patients with ...
I first heard the term “financial toxicity” years ago when I listened to a presentation for oncologists about why patients ...
Here are 7 frequently asked questions about metastatic breast cancer, answered by breast oncologists. When told they have metastatic breast ...
I’ve been asked many times over the past nearly ten years about what I eat now that I have metastatic ...
